Our study demonstrates not only that IRE1 signaling in myeloid cells contributes to LCWE-induced vasculitis development but also that the inhibition of IRE1 RNase activity by a highly specific small molecule can counteract cardiovascular lesions in this model, highlighting IRE1 as a therapeutic target in KD. This evidence concerns the gene ERN1 and vasculitis.